Dr. Anurag K. Singh
Claim this profileRoswell Park Cancer Institute
Studies Skin Cancer
Studies Lung Cancer
15 reported clinical trials
23 drugs studied
Area of expertise
1Skin Cancer
p16 negative
p16 positive
Stage III
2Lung Cancer
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Anurag K. Singh is currently running
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Quality of Life Intervention
for Early-Stage Lung Cancer
This trial studies how providing quality of life information affects decision-making in early-stage lung cancer patients choosing between surgery and radiation therapy. The goal is to help patients make better-informed decisions and feel more satisfied with their care.
Recruiting1 award N/A6 criteria
More about Anurag K. Singh
Clinical Trial Related3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Anurag K. Singh has experience with
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Propranolol
- Stereotactic Body Radiation Therapy
- Photoacoustic Imaging
- Docetaxel
Breakdown of trials Anurag K. Singh has run
Skin Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Anurag K. Singh specialize in?
Is Anurag K. Singh currently recruiting for clinical trials?
Are there any treatments that Anurag K. Singh has studied deeply?
What is the best way to schedule an appointment with Anurag K. Singh?
What is the office address of Anurag K. Singh?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.